Eledon Pharmaceuticals, Inc. (ELDN)
NASDAQ: ELDN · Real-Time Price · USD
3.480
+0.020 (0.58%)
At close: Apr 28, 2026, 4:00 PM EDT
3.539
+0.059 (1.70%)
Pre-market: Apr 29, 2026, 8:13 AM EDT
Eledon Pharmaceuticals Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 264 | 113 | 246 | 44 | 31 | 63 | |
| Market Cap Growth | 56.00% | -53.90% | 465.07% | 38.87% | -50.29% | -72.98% | |
| Enterprise Value | 132 | 21 | 168 | -16 | -34 | -31 | |
| Last Close Price | 3.48 | 1.51 | 4.12 | 1.80 | 2.28 | 4.41 | |
| PB Ratio | 1.92 | 0.83 | 2.08 | 6.04 | 0.37 | 0.39 | |
| P/TBV Ratio | 2.53 | 1.09 | 2.87 | - | 0.61 | 0.76 | |
| Debt / Equity Ratio | 0.01 | 0.01 | 0.01 | 0.05 | 0.01 | 0.01 | |
| Net Debt / Equity Ratio | -0.97 | -0.97 | -1.18 | -7.04 | -0.66 | -0.51 | |
| Net Debt / EBITDA Ratio | - | - | - | - | - | 2.28 | |
| Net Debt / FCF Ratio | 2.13 | 2.13 | 2.95 | 1.28 | 1.96 | 2.91 | |
| Quick Ratio | 7.30 | 7.30 | 12.16 | 13.12 | 8.71 | 19.28 | |
| Current Ratio | 7.40 | 7.40 | 12.42 | 14.41 | 9.19 | 20.07 | |
| Return on Equity (ROE) | -35.79% | -35.79% | -57.73% | -255.03% | -70.89% | -19.46% | |
| Return on Assets (ROA) | -30.04% | -30.04% | -33.11% | -29.56% | -18.88% | -12.53% | |
| Return on Capital Employed (ROCE) | -55.30% | -55.30% | -42.60% | -50.50% | -46.10% | -22.20% | |
| Earnings Yield | -17.26% | -40.20% | -14.70% | -267.55% | -280.45% | -54.69% | |
| FCF Yield | -23.58% | -54.94% | -19.21% | -90.75% | -90.62% | -45.83% | |
| Buyback Yield / Dilution | -68.42% | -68.42% | -97.64% | -72.34% | 3.61% | -921.03% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.